As pioneering work, Ohta reported the regioselective C-5 direct
heteroarylation of oxazole with 2-chloropyrazine under standard
conditions [Pd(PPh3)4/KOAc/DMF].2e The process was further
used to introduce the oxazole nucleus at its position 5 on
heterocyclic pharmaceutics.1a More recently, novel efficient
catalyst systems for C-2 arylation of azoles including the
challenging oxazole were actively developed. Thus, Bellina and
Daugulis reported the first two examples of regioselective direct
C-2 phenylation of oxazole with phenyl iodide or 4-methoxy-
phenyl iodide under base-free conditions2b [CuI (2 equiv), 5
mol % Pd(OAc)2] or palladium-free conditions2c [5 mol % CuI,
tBuOLi (2 equiv)] providing 2-aryloxazoles in 63% or 23%
yields, respectively. Doucet2d and Bhanage2e designed two novel
palladium-bidentate ligand catalysts [PdCl(C3H5)(dppb) and
Pd(TMHD)2] that proved to be effective in C-2 regioselective
arylation of oxazole with 4-tert-butylbromobenzene, iodoben-
zene, or 4-methoxyiodobenzene in 69%, 62%, or 63% yields,
respectively. To date regioselective direct arylation of oxazole
remains sparse compared to the broad range of heterocyclic
targets, and there is a need to develop versatile routes to
(hetero)aryloxazoles via regioselective direct arylation of oxa-
zoles with halo(hetero)arenes. For this purpose, we recently
turned to the commercially available ethyl oxazole-4-carboxylate
1 and we reported the preferential C-2 versus C-5 palladium-
catalyzed direct C-H phenylation of 1 with phenyl iodide under
standard conditions.4 In this note, we report new developments
of this method on the regiocontrolled C-2 (hetero)arylation of
1 followed by a C-5 (hetero)arylation with various (hetero)aryl
halides. This method allows simple and fast access to 2-(het-
ero)aryl- and 2,5-di(hetero)aryloxazole-4-carboxylates, which
are common features of various oxazole-containing natural
products such as the thiopeptide antibiotic GE37468A.5 The
removal of the ethyl carboxylate function used as a temporary
blocking group was examined to prepare the 2-mono(het-
ero)aryl- and 2,5-di(hetero)aryloxazoles via a direct coupling
strategy, which can be directly run to a innovative synthetic
approach toward 2,5-di(hetero)aryloxazole natural products and
scintillators.6
Palladium-Catalyzed Direct (Hetero)arylation of
Ethyl Oxazole-4-carboxylate: An Efficient Access
to (Hetero)aryloxazoles
Ce´cile Verrier, Thibaut Martin, Christophe Hoarau,* and
Francis Marsais
Institut de Chimie Organique Fine (IRCOF) associe´ au
CNRS (UMR 6014), INSA et UniVersite´ de Rouen, BP08
76131 Mont Saint Aignan, France
ReceiVed May 21, 2008
A straightforward route toward 2-(hetero)arylated and 2,5-
di(hetero)arylated oxazoles through regiocontrolled pal-
ladium-catalyzed direct (hetero)arylation of ethyl oxazole-
4-carboxylate with iodo-, bromo-, and chloro(hetero)aromatics
followed by a two-step hydrolysis/decarboxylation sequence
was described. The method was applied here to a neat
synthesis of two 2,5-di(hetero)aryloxazole natural products,
balsoxin and texaline.
(Hetero)aryl-substituted oxazoles are common features of a
wide range of biologically active natural products. They are also
of considerable interest in medicinal chemistry and as organic
materials. In recent years, direct (hetero)arylation has emerged
as an attractive alternative to the commonly employed cross-
coupling reactions because it does not require the rather tricky
preliminary preparation of the requisite metallated or haloge-
nated (hetero)arene. Several reviews highlight the broad scope
of this strategy, high functional group tolerance, atom economy,
and mild reaction conditions.1 However, this straightforward
approach is penalized by the regioselectivity difficulties par-
ticularly with the unsubstituted oxazole at positions 2 and 5.2,3
In the course of the direct phenylation of 1 with phenyl iodide
using a combination of Pd(OAc)2 and Cs2CO3, we proved that
the solvent/ligand pair is of main importance to control the
selectivity of the C-2 arylation versus 5-monoarylation and 2,5-
(3) Examples of C-2 or C-5 direct (hetero)arylations of 5- or 2-monosub-
stituted oxazoles: (a) Besselie`re, F.; Mahuteau-Betzer, F.; Gierson, D. S.; Piguel,
S. J. Org. Chem. 2008, 73, 3278–3280. (b) Ohnmacht, S. A.; Mamone, P.;
Culshaw, A. J.; Greaney, M. F. Chem. Commun. 2008, 10, 1241–1243. (c)
Hodgett, K. J.; Kershaw, M. T. Org. Lett. 2003, 5, 2911–2914. (d) Pivsa-Art,
S.; Fukui, Y.; Miura, M.; Nomura, M. Bull. Chem. Soc. Jpn. 1998, 71, 467–
473. (e) Pivsa-Art, S.; Fukui, Y.; Miura, M.; Nomura, M. Bull. Chem. Soc. Jpn.
1998, 71, 467–473.
(4) Hoarau, C.; Du Fou de Kerdaniel, A.; Bracq, N.; Grandclaudon, P.;
Couture, A.; Marsais, F. Tetrahedron Lett. 2005, 46, 8573–8577.
(5) (a) Hughes, R. A.; Moody, C. Angew. Chem., Int. Ed. 2007, 46, 7930–
7954. (b) Bagley, M. C.; Dale, J. W.; Meritt, E. A.; Xiong, X. Chem. ReV. 2005,
105, 685–714. (c) Yeh, V. S. C. Tetrahedron 2004, 60, 11995–12402.
(6) (a) Charier, S.; Ruel, O.; Baudin, J.-B.; Alcor, D.; Allemand, J.-F.; Meglio,
A.; Jullien, L.; Valeur, B. Chem. Eur. J. 2006, 12, 1097–1113. (b) Clapham, C.;
Sutherland, A. J. Chem. Commun. 2003, 84–85. (c) McCrain, M. C.; Hine, A. V.;
Sutherland, A. J. J. Mater. Chem. 2003, 13, 225–231. (d) Clapham, C.;
Sutherland, A. J. Tetrahedron Lett. 2000, 41, 2253–2256. (e) Diwu, Z.; Zhang,
C.; Klaubert, D. H.; Haugland, R. P. J. Photochem. Photobiol. A: Chem. 2000,
131, 95–100.
(1) (a) Alberico, D.; Scott, M. E.; Lautens, M. Chem. ReV. 2007, 107, 174–
238. (b) Campeau, L.-C.; Stuart, D. R.; Fagnou, K. Aldrichimica Acta 2007, 40,
35–41. (c) Stuart, D. R.; Fagnou, K. Science 2007, 316, 1172–1175. (d) Kakiuchi,
F.; Chatani, N. AdV. Synth. Catal. 2003, 354, 1077–1101. (e) Lablinger, J. A.;
Bercaw, J. E. Nature 2002, 417, 507–514. (f) Ritleng, V.; Sirlin, C.; Pfeffer, M.
Chem. ReV. 2002, 102, 1731–1770. (g) Miura, M.; Nomura, M. Top. Curr. Chem.
2002, 219, 211–241. (h) Fujiwara, Y.; Chengguo, J. Pure Appl. Chem. 2001,
73, 319–324. (i) Dyker, G. Angew. Chem., Int. Ed. 1999, 38, 1698–1712. (j)
Shilov, A.; Shul’pin, G. Chem. ReV. 1997, 97, 2879–2932.
(2) Examples of C-2 or C-5 regioselective direct (hetero)arylations of oxazole:
(a) Derridj, F.; Djebbar, S.; Benali-Baitich, O.; Doucet, H. J. Organomet. Chem.
2008, 693, 135–144. (b) Nandurkar, N. S.; Bhanushali, M. Y.; Bhor, M. D.;
Bhanage, B. M. Tetrahedron Lett. 2008, 49, 1045–1048. (c) Daugulis, O.; Do,
H.-Q. J. Am. Chem. Soc. 2007, 129, 12404–12405. (d) Bellina, F.; Cauteruccio,
S.; Rossi, R. Eur. J. Org. Chem. 2006, 1379–1382. (e) Ohta, A.; Akita, Y.;
Ohkuwa, T.; Chiba, M.; Fukunaga, R.; Miyafuyi, A.; Nakata, T.; Tani, N.;
Aoyagi, Y. Heterocycles 1990, 31, 1951–1958.
10.1021/jo801093n CCC: $40.75
Published on Web 08/15/2008
2008 American Chemical Society
J. Org. Chem. 2008, 73, 7383–7386 7383